Cresco Labs reports Q4 results
Source: SeekingAlpha
2026-03-05 06:33:08 ET
More on Cresco Labs
- Cresco Labs Benefits From Cannabis Rescheduling
- Cresco Labs establishes up to $100M at-the-market equity program
- Trump reportedly seeks finalization of marijuana rescheduling by January-end
- Seeking Alpha’s Quant Rating on Cresco Labs
- Historical earnings data for Cresco Labs
Read the full article on Seeking Alpha
For further details see:
Cresco Labs reports Q4 results
Cresco Labs Inc. (Sub Voting)
NASDAQ: CRLBF
CRLBF Trading
-7.45% G/L:
$0.944 Last:
148,575 Volume:
$0.9428 Open:
CRLBF Latest News
March 05, 2026 06:30:00 am
Cresco Labs Delivers Q4 2025 Revenue of $162 Million and Sequential Margin Improvement
CRLBF Stock Data
$374,894,090
350,757,188
7.22%
23
N/A
Pharmaceuticals
Healthcare
US
Chicago
